Vaping and Smoking Project in People With Schizophrenia

Part of paid clinical trials in Buffalo, New York.

Sponsor
State University of New York at Buffalo
Study ID
NCT06944847
Status
Recruiting

Conditions

  • Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)

Eligibility Criteria

Sex
ALL
Age
21 Years - 50 Years
Healthy Volunteers
Not accepted

Interventions

  • Acute (24-hour) abstinence — BEHAVIORAL
    Participants will be asked to abstain from all tobacco/nicotine for 24 hours prior to the visit
  • Ad libitum smoking/vaping — BEHAVIORAL
    Participants will be asked to smoke/vape as usual during the 24 hours prior to the visit

Study Details

The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.

Key Dates

Start date
Feb 15, 2025
Status verified
Mar 2026
Primary completion
Apr 1, 2027
Completion
Apr 1, 2027

Study Design

Enrollment
64 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE

Arms

  • Other: Daily use of ENDS
    Participants who use nicotine-containing ENDS daily or near-daily but who do NOT smoke combustible cigarettes daily or near-daily.
  • Other: Daily use of combustible cigarettes
    Participants who smoke combustible cigarettes daily or near-daily but do NOT use nicotine-containing ENDS daily or near-daily.

Primary Outcome Measure

Wisconsin Smoking Withdrawal Scale - anger 0.5 [ Time Frame: 0.5 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University at BuffaloBuffaloNew York14260
Larry Hawk, PhD
716-645-0192

Find similar trials in Buffalo, NY

Related Studies